A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

(2018) Alex C. Spyropoulos et al.   NEW ENGLAND JOURNAL OF MEDICINE

The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity

(2018) Thomas P. C. Chu et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Does continuing professional development make good doctors?

(2018) Joseph C. Lee et al.   INTERNAL MEDICINE JOURNAL

Review article: acute severe ulcerative colitis - evidence-based consensus statements

(2016) J.-H. Chen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

(2016) Alexander T. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overview of Venous Thrombosis in Inflammatory Bowel Disease

(2015) Tugrul Purnak et al.   INFLAMMATORY BOWEL DISEASES

Colectomy is a risk factor for venous thromboembolism in ulcerative colitis

(2015) Gilaad G Kaplan   WORLD JOURNAL OF GASTROENTEROLOGY

Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases

(2014) Ashwin N. Ananthakrishnan et al.   Clinical Gastroenterology and Hepatology

Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology

(2014) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY

External Validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for Medical Patients in a Tertiary Health System

(2014) David Rosenberg et al.   Journal of the American Heart Association

Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease

(2013) H. Yuhara et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility

(2013) Russell D. Hull   ANNALS OF INTERNAL MEDICINE

Venous Thromboembolism in Elderly High-Risk Medical Patients

(2013) Russell D. Hull et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Defining High Risk: Cost-Effectiveness of Extended-Duration Thromboprophylaxis Following Major Oncologic Abdominal Surgery

(2013) James C. Iannuzzi et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

(2013) Alexander T. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevention of VTE in Nonsurgical Patients

(2012) Susan R. Kahn et al.   CHEST

Venous Thromboembolism in Inflammatory Bowel Disease: An Epidemiological Review

(2011) Sanjay K Murthy et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE

(2011) Alex C. Spyropoulos et al.   CHEST

Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

(2011) Samuel Z. Goldhaber et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method

(2010) Vinita Bahl et al.   ANNALS OF SURGERY

Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study

(2010) Matthew J Grainge et al.   LANCET

Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients

(2008) Geoffrey C. Nguyen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY